HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online February 18 in eClinicalMedicine.

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver College of Medicine and a member of the U.S. Food and Drug Administration’s ...

COVID-19 cases and hospitalizations are on the rise again ahead of the busy holiday travel season. Dr. Eric Cioe-Peña joins CBSN to discuss what this means for families planning to gather this ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Among women who never got sick, researchers found the shots appeared to improve vascular and immune health. For mothers with ...

Health experts are reinforcing the point that full vaccination remains highly effective against severe illness and death caused by COVID-19 as federal regulators consider the possibility of ...

The US Centers for Disease Control and Prevention strengthened recommendations for booster doses of coronavirus vaccine Monday, saying all adults should get boosted six months after the second dose of ...

PHILADELPHIA -- To help fend off another wave of Covid-19, people will need a fourth dose of vaccine, Pfizer CEO Albert Bourla said Sunday. "Many variants are coming, and Omicron was the first one ...

Booster vaccines reduced the risk of COVID‑19-related hospitalization and death, according to a new study of over 3 million ...

A new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has ...

The U.S. Food and Drug Administration has authorized booster shots of the Moderna and Pfizer COVID-19 vaccines for all adults ages 18 and older. On Friday, the FDA announced it had amended the ...